Mr. Knight joined Poseida as vice president of clinical development operations and project management in October of 2018. He has over 20 years of clinical drug development experience including clinical operations, data management, project/portfolio management, regulatory affairs, clinical outsourcing, supplier governance, clinical supply chain, medical writing, and strategic planning. Most recently, he was vice president of clinical development operations and project management at Halozyme Therapeutics. Previously, he was an executive director of global development operations at Amgen after serving as vice president of clinical operations and project management at Onyx Pharmaceuticals (an Amgen subsidiary). He initially joined Onyx as a senior director of clinical development. Prior to that, he held several leadership roles of increasing responsibility in clinical operations, regulatory affairs, and project management at Genentech, PRA International, and Hoechst Marion Roussel (now Sanofi). Mr. Knight earned an MPH in biostatistics and epidemiology and a BA in psychology from the University of Oklahoma Health Sciences Center. He also earned a BS in nursing from the University of Kansas Medical Center.